Skip to content
Zenlabs Ethica logo

Zenlabs Ethica

530697 BSE
Price unavailable

Zenlabs Ethica (ZENLABS) share price was ₹26.15 at the 28 Oct 2026 close; market capitalisation ₹16.99 Cr; sector Commercial Services. The share price fell 9.8% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 23.5% year on year to ₹14.18 Cr and net profit was −₹0.57 Cr, against ₹0.03 Cr a year earlier (compared with Jun 2025). Promoters held 52.96% of Zenlabs Ethica in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 53/100 (Average) as of 28 Oct 2026.

Close 28 Oct 2026 ₹26.15 −3.70 −12.40% 1Y

Key Fundamentals

MicrocapCommercial ServicesServices
Market Cap
₹16.99 Cr
EBITDA
₹2.00 Cr
Return on Equity
-22.73%
Debt to Equity
1.29
Book Value
₹13.08
EPS (TTM)
−₹3.91
52W High
₹39.99
52W Low
₹16.50

Price-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Standalone · TTM

Peer Comparison

Services › Commercial Services › Diversified Services › Diversified Commercial Services

International Gemological Institute
₹405.8028.7617,537 Cr10.020.65%47.80%58.83%1,521 Cr611 Cr
WeWork India Management
₹630.70103.568,759 Cr25.730.00%64.94%11.08%2,850 Cr82 Cr
Indiabulls
₹31.7817.097,412 Cr2.080.00%11.14%6.24%1,121 Cr488 Cr
Nesco
₹1,002.1016.957,061 Cr2.240.71%13.77%15.50%1,055 Cr417 Cr
Nirlon
₹630.9015.935,686 Cr12.134.76%73.83%23.30%689 Cr357 Cr
Leap India
₹119.50—5,264 Cr3.480.00%6.19%9.00%821 Cr75 Cr
Zenlabs Ethica (this company)
——17 Cr2.000.94%-22.73%-9.94%50 Cr-3 Cr
Median 7 companies₹518.2517.097,061 Cr3.480.65%13.77%11.08%1,055 Cr357 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

53 Average
Overall score

Data confidence 91/100

Category scores

Quality Average 54
Returns, margins, earnings quality 22% weight
Valuation Good 61
Cheap vs sector & own history 24% weight
Growth Weak 42
Sales & profit trajectory 9% weight
Financial Health Poor 12
Solvency, leverage, coverage 9% weight
Momentum Strong 75
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Weaknesses

5
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -3.70% over past five years.
  • Company has a low return on equity of 2.39% over last 3 years.
  • Company might be capitalizing the interest cost
  • Promoter holding has decreased over last 3 years: -6.16%

Technical Indicators

Oscillators

Neutral

Bearish
2
Neutral
5
Bullish
2

Overall

Bearish

Bearish
12
Neutral
5
Bullish
2

Moving Averages

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
-8.54% higher than 3Y

change over 1 year

Net Income Growth
-733% lower than 3Y

change over 1 year

Cash Flow Change
6.01%

change over 1 year

EBITDA Margin Change
-17.72%

change over 1 year Operating margin -2.05% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
13.57
14.06
15.6
15.33
12.36
13.35
12.72
12.99
11.48
12.43
12.43
10.58
14.18
Expenses
13.04
13.62
14.91
14.57
11.74
12.73
12.04
12.33
10.93
11.98
11.91
10.31
14.47
Operating Profit
0.53
0.44
0.69
0.76
0.62
0.62
0.68
0.66
0.55
0.45
0.52
0.27
-0.29
OPM %
3.91%
3.13%
4.42%
4.96%
5.02%
4.64%
5.35%
5.08%
4.79%
3.62%
4.18%
2.55%
-2.05%
Other Income
0.05
0.22
0
0.02
0
0
0
0.04
0
0.06
-2.08
0.12
0
Interest
0.16
0.21
0.22
0.25
0.23
0.23
0.24
0.23
0.21
0.19
0.23
0.18
0.16
Depreciation
0.32
0.32
0.32
0.33
0.32
0.31
0.32
0.31
0.29
0.24
0.23
0.14
0.11
PBT
0.1
0.13
0.15
0.2
0.07
0.08
0.12
0.16
0.05
0.08
-2.02
0.07
-0.56
Tax %
30%
30.77%
26.67%
25%
42.86%
25%
33.33%
43.75%
20%
50%
0%
114.29%
3.57%
Net Profit
0.07
0.09
0.11
0.15
0.04
0.05
0.09
0.09
0.03
0.04
-2.01
0
-0.57
EPS (₹)
0.11
0.14
0.17
0.23
0.06
0.08
0.14
0.14
0.05
0.06
-3.09
0
-0.88
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
0
15.09
78.73
69.85
65.37
58.5
56.64
69.09
66.89
58.56
51.42
46.92
49.62
Expenses
0.05
14.89
77.28
68
63.28
59.2
54.89
66.7
63.98
56.15
48.84
45.13
48.67
Operating Profit
-0.05
0.2
1.45
1.85
2.09
-0.7
1.75
2.39
2.91
2.41
2.58
1.79
0.95
OPM %
—
1.33%
1.84%
2.65%
3.2%
-1.2%
3.09%
3.46%
4.35%
4.12%
5.02%
3.82%
1.91%
Other Income
0
-0.03
0.08
0.1
0.1
0.05
0.11
0.09
-0.45
0.3
0.04
-1.9
-1.9
Interest
0
0.02
0.1
0.09
0.07
0.23
0.29
0.37
0.53
0.83
0.93
0.81
0.76
Depreciation
0.01
0.06
0.2
0.2
0.23
0.29
0.71
0.89
1.25
1.29
1.26
0.89
0.72
PBT
-0.06
0.09
1.23
1.66
1.89
-1.17
0.86
1.22
0.68
0.59
0.43
-1.81
-2.43
Tax %
16.67%
-88.89%
21.95%
29.52%
32.8%
-36.75%
10.47%
36.07%
26.47%
27.12%
37.21%
6.63%
—
Net Profit
-0.07
0.17
0.95
1.16
1.26
-0.73
0.77
0.78
0.49
0.42
0.27
-1.94
-2.54
EPS (₹)
-0.18
0.26
1.46
1.78
1.94
-1.12
1.18
1.2
0.75
0.65
0.41
-2.98
-3.91
Div. Payout %
0%
0%
16.32%
0%
0%
0%
0%
0%
33.21%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
3.62
6.2
6.2
6.2
6.51
6.51
6.51
6.51
6.51
6.51
6.51
6.51
Reserves
-1.65
-1.41
-0.41
0.81
1.77
0.9
2.05
2.82
3.19
3.61
3.92
2
Borrowings
0
1.09
0.96
0.85
0.6
0.73
2.6
3.9
5.85
14.86
12.71
10.98
Other Liabilities
1.77
24.49
26.62
21.96
26.01
25.85
21.04
24.66
27.95
15.28
17.48
17.71
Total Liabilities
3.74
30.37
33.37
29.82
34.89
33.99
32.2
37.89
43.5
40.26
40.62
37.2
Fixed Assets
0.06
1.68
1.5
1.33
1.36
1.12
3.51
3.53
5.03
3.7
2.29
1.87
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0
1.25
0.95
0.7
0.7
0.7
0.7
0.7
0.7
0.7
0.7
0
Other Assets
3.68
27.44
30.92
27.79
32.83
32.17
27.99
33.66
37.77
35.86
37.63
35.33
Total Assets
3.74
30.37
33.37
29.82
34.89
33.99
32.2
37.89
43.5
40.26
40.62
37.2
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0.02
0.92
-1.06
0.36
0.8
0.45
-8.41
-0.38
1.52
-9.06
3.83
4.06
Investing
0
-1.69
-0.02
-0.03
-0.22
0.01
0.15
0
-1.47
0.11
0.14
0
Financing
0
3.23
-0.27
-0.23
-0.14
-0.03
-0.52
0.31
0.06
8.24
-3.08
-2.95
Net Cash Flow
0.02
2.47
-1.35
0.09
0.44
0.43
-8.78
-0.07
0.11
-0.71
0.88
1.11
Free Cash Flow
0.02
-0.77
-1.08
0.33
0.49
0.4
-8.35
-0.41
-0.03
-9.08
3.96
4.06
CFO/OP
-40
460
-73
19
38
-64
-475
-11
62
-371
157
234
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
—
398
108
126
139
139
122
110
118
129
139
122
Inventory Days
—
250
34.42
11.12
31.23
33.95
40.46
56.05
77.85
100
128
161
Days Payable
—
665
136
126
161
165
150
141
174
101
140
165
Cash Conversion Cycle
—
-17.7
5.66
11.64
9.33
7.4
11.85
24.32
22.21
128
127
118
Working Capital Days
—
4.84
13.4
21.95
28.42
24.02
27.97
35.34
34.98
47.31
52.74
39.44
ROCE %
-2.99%
9.94%
21.06%
23.96%
24.13%
-11.05%
12.02%
13.04%
12.44%
7.01%
5.69%
5.07%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Zenlabs Ethica insights

61 extracted metrics + investor summaries across FY08–FY27.

Shareholding Pattern

Promot.52.96%Others8.44%Public38.60%As ofSep 2026

Documents

Frequently Asked Questions about Zenlabs Ethica

What does Zenlabs Ethica Ltd do?
Incorporated in 1993, Zenlabs Ethica Ltd deals in marketing and distribution of pharmaceutical products.[1]
Where is Zenlabs Ethica Ltd (ZENLABS) listed?
Zenlabs Ethica Ltd trades under code 530697 on the BSE.
Which sector does Zenlabs Ethica Ltd belong to?
Zenlabs Ethica Ltd is classified under the Commercial Services sector, in the Diversified Services industry.
What is the market capitalisation of Zenlabs Ethica Ltd?
Zenlabs Ethica Ltd has a market capitalisation of ₹16.99 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Zenlabs Ethica Ltd?
Over the last 52 weeks Zenlabs Ethica Ltd has traded between ₹16.5 and ₹39.99 as of 28 Oct 2026.
Does Zenlabs Ethica Ltd pay dividends?
Zenlabs Ethica Ltd has a dividend yield of 0.96%.
What is the Return on Equity (ROE) of Zenlabs Ethica Ltd?
Zenlabs Ethica Ltd reported a return on equity of -22.73%. Its debt-to-equity ratio is 1.29.

Company Information

Incorporated in 1993, Zenlabs Ethica Ltd deals in marketing and distribution of pharmaceutical products.[1]

Website zenlabsindia.com ; www.zenlabsethica.com
Face Value ₹ 10
Shares Outstanding 64,97,948

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/530697.md for Zenlabs Ethica Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Commercial Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month